Eric Drape's most recent trade in Teva- Pharmaceutical Industries Ltd. - ADR was a trade of 55,226 Restricted Share Units done . Disclosure was reported to the exchange on March 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teva- Pharmaceutical Indus... | Eric Drape | Executive VP Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 55,226 | 0 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Eric Drape | Executive VP Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 55,226 | 145,915 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Eric Drape | Executive VP Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 22,576 | 22,576 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Eric Drape | Executive VP Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 22,576 | 90,689 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Eric Drape | Executive VP Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 33,512 | 77,928 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Eric Drape | Executive VP Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 33,512 | 67,024 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Eric Drape | Executive VP Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 24,900 | 44,416 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Eric Drape | Executive VP Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 24,900 | 74,701 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Eric Drape | Executive VP Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 19,515 | 19,516 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Eric Drape | Executive VP Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 19,515 | 0 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Drape Eric | Executive VP Global Operations | Sale of securities on an exchange or to another person at price $ 13.12 per share. | 28 Feb 2024 | 9,815 | 9,701 (0%) | 0% | 13.1 | 128,734 | Ordinary Shares |
| Teva- Pharmaceutical Indus... | Eric Drape | Executive VP Global Operations | Sale of securities on an exchange or to another person at price $ 13.05 per share. | 16 Feb 2024 | 173,261 | 1 (0%) | 0% | 13.1 | 2,261,905 | Ordinary Shares |
| Teva- Pharmaceutical Indus... | Eric Drape | Executive VP Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 55,226 | 55,226 | - | - | Restricted Share Units |